Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP810919.RAUTqR-qqGC23rd7p1i3Sylpqczg4zkyRTtDD7d1uwmus130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP810919.RAUTqR-qqGC23rd7p1i3Sylpqczg4zkyRTtDD7d1uwmus130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP810919.RAUTqR-qqGC23rd7p1i3Sylpqczg4zkyRTtDD7d1uwmus130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP810919.RAUTqR-qqGC23rd7p1i3Sylpqczg4zkyRTtDD7d1uwmus130_provenance.
- NP810919.RAUTqR-qqGC23rd7p1i3Sylpqczg4zkyRTtDD7d1uwmus130_assertion description "[High-level MAD2 expression was observed in 26.3% (94 of 358 cases), and correlated with male sex (P=0.0002), tumor progression (pT status) (P=0.0009), visceral or parietal pleural invasion (P=0.0151), non-adenocarcinoma, histological classification (P<0.0001), and smoking history (P=0.0022), but not with patient age or lymph node metastasis (pN status).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP810919.RAUTqR-qqGC23rd7p1i3Sylpqczg4zkyRTtDD7d1uwmus130_provenance.
- NP810919.RAUTqR-qqGC23rd7p1i3Sylpqczg4zkyRTtDD7d1uwmus130_assertion evidence source_evidence_literature NP810919.RAUTqR-qqGC23rd7p1i3Sylpqczg4zkyRTtDD7d1uwmus130_provenance.
- NP810919.RAUTqR-qqGC23rd7p1i3Sylpqczg4zkyRTtDD7d1uwmus130_assertion SIO_000772 21376419 NP810919.RAUTqR-qqGC23rd7p1i3Sylpqczg4zkyRTtDD7d1uwmus130_provenance.
- NP810919.RAUTqR-qqGC23rd7p1i3Sylpqczg4zkyRTtDD7d1uwmus130_assertion wasDerivedFrom befree-20140225 NP810919.RAUTqR-qqGC23rd7p1i3Sylpqczg4zkyRTtDD7d1uwmus130_provenance.
- NP810919.RAUTqR-qqGC23rd7p1i3Sylpqczg4zkyRTtDD7d1uwmus130_assertion wasGeneratedBy ECO_0000203 NP810919.RAUTqR-qqGC23rd7p1i3Sylpqczg4zkyRTtDD7d1uwmus130_provenance.
- befree-20140225 importedOn "2014-02-25" NP810919.RAUTqR-qqGC23rd7p1i3Sylpqczg4zkyRTtDD7d1uwmus130_provenance.